Lab Automation Market Size & Share 2024 to 2032
Market Size by Product Type (Equipment, Software), by Application (Drug Discovery, Genomics, Proteomics, Clinical Diagnostics), by End Use (Pharmaceutical & Biotechnology Companies), & Forecast.
Report ID: GMI5951
|
Published Date: June 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Lab Automation Market Size
Lab Automation Market size was valued at around USD 6.7 billion in 2023 and is anticipated to register a CAGR of over 6.7% between 2024 and 2032.
Lab Automation Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
The field of lab automation has been experiencing significant growth and transformation in recent years. Several market trends have emerged that are shaping the lab automation landscape. The adoption of robotics in laboratory settings is driven by the need to automate repetitive and labour-intensive tasks, thereby reducing human error, improving accuracy, and increasing throughput. Robotic systems, such as robotic arms and workstations, are equipped with advanced features like grippers, vision systems, and precise movement capabilities.
These systems can handle a variety of tasks, including sample handling, pipetting, plate handling, and assay preparation. The integration of robotics enables laboratories to achieve higher productivity, standardization, and reproducibility in their workflows. These trends reflect the ongoing evolution of lab automation, driven by the need for improved efficiency, productivity, data management, and integration across various scientific disciplines. The lab automation market is expected to continue growing as more laboratories recognize the benefits and value that automation brings to their workflows.
Lab automation refers to the use of technology and automated systems to streamline and optimize laboratory processes, reducing manual intervention, improving efficiency, accuracy, and productivity. Lab automation encompasses various aspects of laboratory operations, including sample handling, analysis, data management, and reporting. Lab automation offers numerous benefits, including increased throughput, improved data quality, reduced turnaround times, enhanced experimental reproducibility, and improved overall laboratory efficiency.
The high cost of lab automation robotic systems may negatively impact the market growth, as it may limit the affordability and accessibility of these devices for some end-users, especially in the emerging economies. While lab automation offers numerous benefits, there are challenges associated with the cost factor. Implementing lab automation, especially robotic systems, requires a substantial initial investment. The cost includes not only the purchase of the automation equipment but also the necessary infrastructure modifications, software integration, and staff training.
The upfront cost can be prohibitive for some laboratories, especially those with limited budgets or smaller-scale operations. To mitigate the market restraint of high costs, several approaches can be considered. These include exploring collaborative partnerships or shared-use facilities to distribute the investment burden, evaluating financing options or leasing arrangements, and engaging with automation vendors to negotiate pricing or explore cost-effective solutions.
COVID-19 Impact
The emergence of COVID-19 is an unprecedented public health concern that had negatively affected the lab automation market growth. Nation-wide lockdowns, and emergencies were imposed in various countries and maintaining crucial medical resources was given priority owing to COVID-19. The pandemic had caused disruptions in global supply chains, affecting the manufacturing and distribution of lab automation equipment and components. Restrictions on international trade, reduced workforce capacity, and increased demand for healthcare supplies had led to delays in equipment delivery and limited availability of certain components.
Also, the economic impact of the pandemic had resulted in budget cuts and reduced research funding in many organizations. This had constrained the financial resources available for investments in lab automation, making it challenging for some laboratories to allocate funds to automation projects. Although, the market is set to witness significant growth in the coming years with the surging product and service adoption.
Lab Automation Market Trends
The clinical research & laboratory sector is witnessing a significant rise in investment in healthcare infrastructure, driven by the increasing demand for advanced medical facilities and the need to improve healthcare outcomes. This surge in investment is playing a crucial role in driving the market forward. Lab automation, with its ability to enhance efficiency, accuracy, and productivity, has become a compelling solution for healthcare organizations looking to optimize their operations and leverage the latest technological advancements. With these developments, there is a growing focus on integrating cutting-edge technologies, including lab automation systems, into the infrastructure to deliver higher-quality and more efficient healthcare services.
Lab automation offers a range of benefits that align with the objectives of healthcare infrastructure development. By automating laboratory processes, it enables healthcare providers to handle a larger volume of samples, conduct tests with greater speed and precision, and generate more reliable results.
The implementation of lab automation systems is particularly beneficial for high-throughput environments, such as large hospitals, diagnostic laboratories, and research institutions. These automated systems enable healthcare professionals to process a higher number of samples in a shorter time, facilitating faster diagnoses, treatment decisions, and research outcomes. This increased efficiency supports the overall goal of healthcare infrastructure investment, which is to provide timely and effective healthcare services to a larger population.
Lab Automation Market Analysis
Based on product type, the lab automation market is segmented as equipment and software. Equipment segment accounted for majority market share in 2022 and was valued at more than USD 4.7 billion. This majority revenue share is primarily attributed to the higher preference and adoption of lab automation equipment to optimize clinical workflow. Automated equipment & systems are primarily used for sample preparation, pipetting, and dispensing. These systems provide precise and error-free liquid handling capabilities, enabling laboratories to process large volumes of samples efficiently.
The demand for automated liquid handling systems is driven by their ability to reduce manual errors, increase throughput, and improve data reproducibility, which are critical factors in various scientific research and diagnostic applications. Thus, the the advantages offered by lab automation equipment in streamlining laboratory workflows, improving efficiency, and enhancing data accuracy are some of the key variables that are expected to drive the business progress.
Based on application, the lab automation market is segmented as drug discovery, genomics, proteomics, clinical diagnostics, and others. The clinical diagnostics segment accounted for the largest revenue share in 2022 and is expected to propel at a 6.3% CAGR from 2023-2032. This highest market share is due to the higher adoption & increased demand for lab automation solutions in clinical diagnostics. The application of lab automation in clinical diagnostics spans various areas, including molecular diagnostics, immunoassays, hematology, clinical chemistry, microbiology, and genetic testing. In molecular diagnostics, lab automation systems enable automated nucleic acid extraction, PCR setup, and DNA sequencing, allowing for high-throughput and standardized testing.
This automation improves accuracy, reduces hands-on time, and enhances the efficiency of molecular diagnostic workflows, enabling faster and more reliable results. Immunoassays, another crucial area in clinical diagnostics, benefit from lab automation through automated sample handling, reagent dispensing, and result analysis. Automation streamlines the entire immunoassay process, ensuring consistent and precise measurements while reducing manual errors and enhancing laboratory productivity.
Based on end-use, the lab automation market is segmented as pharmaceutical & biotechnology companies, diagnostic labs, research & academic institutes, and others. The pharmaceutical & biotechnology companies segment accounted for majority revenue share and was valued at over USD 2.6 billion in 2022. This significant segment growth is majorly attributed to the increasing adoption of lab automation solutions by pharmaceutical and biotechnology companies. Pharmaceutical and biotech companies utilize lab automation across various stages of drug development, including high-throughput screening, compound management, assay development, and quality control. Automation systems enable these companies to process large volumes of samples, improve assay precision, and accelerate the drug discovery process.
By automating repetitive tasks and data analysis, lab automation enhances efficiency, reduces time-to-market, and increases the success rate of identifying promising drug candidates. Moreover, lab automation is instrumental in optimizing pharmaceutical manufacturing processes. It ensures accurate formulation and dispensing of ingredients, streamlines sample preparation, and facilitates quality control testing. Automation systems help in achieving consistent batch-to-batch production, minimizing human errors, and ensuring compliance with regulatory standards. With a wide range of automation solutions catering to specific needs, the market continues to thrive, supporting the growth and advancements in the pharmaceutical and biotech industries.
U.S. lab automation market is predicted to reach over USD 3.7 billion by 2032. This dominant market growth is primarily owing to several variables including the robust healthcare sector, increasing adoption of lab automation solutions, advanced research facilities, and a strong presence of pharmaceutical and biotechnology companies. Pharmaceutical and biotechnology companies are major contributors to the growth of the market in the U.S. These companies utilize lab automation systems for various applications, including drug discovery, compound management, high-throughput screening, and quality control. Automation solutions enable them to accelerate the drug development process, increase efficiency in manufacturing, and improve the overall quality of pharmaceutical products.
In addition to healthcare and life sciences, the U.S. has a thriving research and academic sector that extensively employs lab automation systems. Research institutions, universities, and government laboratories leverage lab automation to enhance productivity, standardize processes, and drive innovation in scientific research across various disciplines. The increased adoption of lab automation solutions across diverse end-user industries such as healthcare, pharmaceuticals, and research institutions and the rising demand towards healthcare laboratory informatics for efficiency, accuracy, & productivity in laboratory operations is further fuelling the regional market growth.
Lab Automation Market Share
Some of the major players operating in the lab automation market include:
These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.
Lab Automation Industry Leaders:
Lab automation market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments:
Click here to Buy Section of this Report
By Product Type, 2018 - 2032 (USD Million)
By Application, 2018 - 2032 (USD Million)
By End-use, 2018 - 2032 (USD Million)
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →